BEBT-109

BEBT-109 · BeBetter Med Inc

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BEBT-109, covering 2024-07-23 to 2024-11-26. Get the full timeline:

Most recent: Clinical Trial Update: Study of BEBT-109 in Subjects With EGFR Exon 20 Insertion Mutations Non-Small Cell Lung Cancer [Phase 2]